Annual CFO
-$7.72 M
-$5.46 M-240.91%
31 December 2023
Summary:
Conduit Pharmaceuticals annual cash flow from operations is currently -$7.72 million, with the most recent change of -$5.46 million (-240.91%) on 31 December 2023. During the last 3 years, it has fallen by -$5.57 million (-259.14%). CDTTW annual CFO is now -259.14% below its all-time high of -$2.15 million, reached on 31 December 2021.CDTTW Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.00 M
-$486.00 K-32.12%
30 September 2024
Summary:
Conduit Pharmaceuticals quarterly cash flow from operations is currently -$2.00 million, with the most recent change of -$486.00 thousand (-32.12%) on 30 September 2024. Over the past year, it has increased by +$2.80 million (+58.38%). CDTTW quarterly CFO is now -281.49% below its all-time high of -$524.00 thousand, reached on 30 September 2023.CDTTW Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$10.67 M
-$1.48 M-16.04%
30 September 2024
Summary:
Conduit Pharmaceuticals TTM cash flow from operations is currently -$10.67 million, with the most recent change of -$1.48 million (-16.04%) on 30 September 2024. Over the past year, it has dropped by -$5.34 million (-100.34%). CDTTW TTM CFO is now -1936.64% below its all-time high of -$524.00 thousand, reached on 30 September 2023.CDTTW TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTTW Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +58.4% | -100.3% |
| 3 y3 years | -259.1% | - | - |
| 5 y5 years | - | - | - |
CDTTW Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -259.1% | at low | -281.5% | +58.4% | -1936.6% | at low |
| 5 y | 5 years | -259.1% | at low | -281.5% | +58.4% | -1936.6% | at low |
| alltime | all time | -259.1% | at low | -281.5% | +58.4% | -1936.6% | at low |
Conduit Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.00 M(+32.1%) | -$10.67 M(+16.0%) |
| June 2024 | - | -$1.51 M(-35.8%) | -$9.20 M(+19.7%) |
| Mar 2024 | - | -$2.36 M(-50.9%) | -$7.68 M(+44.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$7.72 M(+240.9%) | -$4.80 M(+816.6%) | -$5.33 M(+916.6%) |
| Sept 2023 | - | -$524.00 K | -$524.00 K |
| Dec 2022 | -$2.27 M(+5.3%) | - | - |
| Dec 2021 | -$2.15 M | - | - |
FAQ
- What is Conduit Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals quarterly CFO year-on-year change?
- What is Conduit Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Conduit Pharmaceuticals?
- What is Conduit Pharmaceuticals TTM CFO year-on-year change?
What is Conduit Pharmaceuticals annual cash flow from operations?
The current annual CFO of CDTTW is -$7.72 M
What is the all time high annual CFO for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high annual cash flow from operations is -$2.15 M
What is Conduit Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of CDTTW is -$2.00 M
What is the all time high quarterly CFO for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high quarterly cash flow from operations is -$524.00 K
What is Conduit Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, CDTTW quarterly cash flow from operations has changed by +$2.80 M (+58.38%)
What is Conduit Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of CDTTW is -$10.67 M
What is the all time high TTM CFO for Conduit Pharmaceuticals?
Conduit Pharmaceuticals all-time high TTM cash flow from operations is -$524.00 K
What is Conduit Pharmaceuticals TTM CFO year-on-year change?
Over the past year, CDTTW TTM cash flow from operations has changed by -$5.34 M (-100.34%)